Institutional investors purchased a net $1.7 million shares of EBS during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 88.77% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 559.1 Thousand shares of Emergent BioSolutions Inc